Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogenes are genomic sequences similar to the 5S rRNA gene, but lacking functional activity due to mutations, truncations, or lack of regulatory elements required for transcription or translation. RNA5SP178 is one of many processed pseudogenes corresponding to the canonical 5S rRNA gene in the human genome. While canonical 5S rRNA is an essential structural component of the ribosome and involved in protein synthesis, pseudogenes are typically nonfunctional remnants that may rarely acquire regulatory capacity (for example, acting as ceRNAs) in specific disease contexts, but this is uncommon and not established for RNA5SP178. No drugs, therapeutic mechanisms, or biomarker roles are associated with RNA5SP178. In summary, RNA5SP178 is not a functional gene, receptor, enzyme, nor a recognized target in therapeutic development. Its classification is a pseudogene, reflecting an inactive, non-coding RNA sequence related to 5S rRNA, with no established biological or clinical relevance.
Not applicable; no mechanism of action involving drugs is known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 178 (RNA5SP178).